According to The Kobeissi Letter, President Trump announced via Truth Social that he will sign an Executive Order to reduce drug prices by 30% to 80% tomorrow (source: The Kobeissi Letter, May 11, 2025). This policy is expected to significantly impact pharmaceutical stocks, potentially leading to heightened volatility and selloffs in the healthcare sector. Crypto traders should monitor for increased capital rotation out of pharma stocks and into digital assets, as regulatory shocks often spur safe-haven demand for Bitcoin and Ethereum during market uncertainty.

According to The Kobeissi Letter, President Trump announced on Truth Social that he will sign an Executive Order to reduce drug prices by 30% to 80%, a move expected to significantly impact pharmaceutical stocks and influence broader market sentiment. This development could lead to increased volatility in healthcare equities (source: The Kobeissi Letter, May 11, 2025). Crypto markets may experience a risk-off reaction if stock market turbulence spills over, especially as investors seek alternative assets amid regulatory and policy uncertainty surrounding major sectors.